The mode of endoscopic surveillance in patients with atrophic gastritis and intestinal metaplasia depends on the location of the lesions (body and/or antrum) and the following risk factors: family history of gastric cancer, persistent H. pylori infection, incomplete intestinal metaplasia and a diagnosis of autoimmune gastritis. |
Quality of evidence: moderate. Recommendation: strong. |